Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzonatate soft capsules for adult cough
NCT03722914Phase 3Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cough comparing Benzonatate Group with Placebo Group (2 arms). Primary endpoint: Reduction of cough symptoms total scores at 7 days. Status: unknown.
02
Drugs
benzonatate
03
Conditions
cough
Beyond the preview
Go deeper on NCT03722914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03722914.